Rensselaer Polytechnic Institute Awarded $3.3 Million Grant to Improve mRNA Purification Technology
Research aims to address a critical bottleneck in the production of mRNA therapeutics.
RPI Researchers Aim to Manufacture mRNA More Affordably
Biotechnology researchers at Rensselaer Polytechnic Institute (RPI) are working to further improve mRNA therapeutics, with the aim of reducing manufacturing costs and enabling additional therapeutic uses for mRNA technology.